Association CRYOSTEM – Trademark Portfolio
Entity Type: 99
Association CRYOSTEM holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include ADKINS-BIOSCIENCES.
Institut Paoli-Calmettes,
232 boulevard Sainte-Marguerite F-13009M
Showing of trademarks Trademarks
Trademark Classifications
Association CRYOSTEM's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Association CRYOSTEM have?
Association CRYOSTEM has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does Association CRYOSTEM file in?
Association CRYOSTEM files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 41 (Education & Entertainment), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Association CRYOSTEM's most well-known trademarks?
Association CRYOSTEM's registered trademark portfolio includes well-known marks such as ADKINS-BIOSCIENCES. These are among 1 currently registered trademark in the portfolio.
What is Association CRYOSTEM's trademark registration success rate?
Association CRYOSTEM has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.